
Technology
Nuclide Therapeutics is pioneering precision radionuclide therapies that directly target and destroy resistant cancer cells, offering a new treatment pathway following the failure of conventional therapies.
Urgent Need
Despite major advances in precision medicine, therapy resistance continues to limit long-term survival in hard-to-treat cancers, such as lung cancer, and demands entirely new therapeutic approaches.

18 Million
18 million new cancer cases every year
8 Million
Deaths from therapy resistant cancer
Lung Cancer
The leading cause of cancer-related death worldwide
Precision radiotheranostics
Nuclide Therapeutics is developing a new generation of radiopharmaceuticals designed to precisely identify and destroy resistant cancer cells.





